Multi-Modal Anesthesia Protocol in Pain Management of Patients Undergoing Posterior Lumbar Spinal Fusion Surgery
Status:
Completed
Trial end date:
2022-03-23
Target enrollment:
Participant gender:
Summary
This study consisted of a randomized controlled trial designed to evaluate a Multimodal
Analgesia (MMA) Protocol on patients undergoing Posterior Spinal Fusion. The purpose is to
describe the narcotic requirements and usage during the perioperative period of posterior
spinal fusion and instrumentation surgery with the implementation of multimodal anesthesia
protocol. The study will consist of two parallel arms, with Group 1 receiving our MMA
protocol and Group 2 receiving a traditional opioid-based regime. The primary outcome of this
study will be the reported Visual Analog Scale (VAS) for pain at 12, 24, and 48 hours after
surgery. We considered that our findings could contribute to the fight against the opioid
crisis proving alternatives to opioids as feasible alternatives for pain management even in
significant surgery, as is posterior spinal fusion with instrumentation.